WA
ZBH icon

WESPAC Advisors’s Zimmer Biomet ZBH Stock Holding History

WESPAC Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,814
Closed -$452K – 142
2017
Q1 		$452K Buy
+3,814
New +$432K 0.52% 63
2016
Q4 		– Sell
-4,162
Closed -$525K – 143
2016
Q3 		$525K Buy
+4,162
New +$514K 0.59% 62

Other funds holding ZBH

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

WESPAC Advisors's ZBH Position: Q2 2017 in Review

WESPAC Advisors sold out of Zimmer Biomet (ZBH) in Q2 2017, closing a stake of 3,814 shares — an estimated $452K sold.

WESPAC Advisors first reported a position in ZBH in Q3 2016 and held it in 2 quarters. The position peaked at $525K in Q3 2016. 819 funds tracked by Wall St. Rank hold ZBH as of Q2 2017.

  • WESPAC Advisors reported no remaining Zimmer Biomet position as of Q2 2017 after selling out during the quarter.
  • WESPAC Advisors sold 3,814 Zimmer Biomet shares in Q2 2017, an estimated $452K.
  • WESPAC Advisors first reported a position in Zimmer Biomet in Q3 2016 and held it in 2 quarters.
  • WESPAC Advisors's Zimmer Biomet position peaked at $525K in Q3 2016.
  • 819 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2017.

Based on WESPAC Advisors's 13F filing for Q2 2017, filed 10 Aug 2017.